X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2003) 2003
Publication (328) 328
Book Review (48) 48
Book Chapter (16) 16
Book / eBook (12) 12
Conference Proceeding (9) 9
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1331) 1331
animals (1030) 1030
index medicus (1015) 1015
complement (696) 696
immunology (643) 643
complement activation (459) 459
mice (457) 457
inflammation (408) 408
male (407) 407
female (350) 350
activation (310) 310
proteins (218) 218
article (216) 216
complement c5 - antagonists & inhibitors (209) 209
c5a (197) 197
disease models, animal (197) 197
analysis (190) 190
biochemistry & molecular biology (184) 184
complement system proteins - immunology (179) 179
research (165) 165
mice, inbred c57bl (159) 159
rats (151) 151
expression (147) 147
hematology (147) 147
cell biology (146) 146
innate immunity (141) 141
health aspects (135) 135
complement activation - drug effects (134) 134
complement system proteins - metabolism (133) 133
adult (132) 132
mice, knockout (128) 128
middle aged (128) 128
cytokines (127) 127
complement system (124) 124
research article (117) 117
medicine, research & experimental (116) 116
physiological aspects (116) 116
transplantation (111) 111
immune system (110) 110
neutrophils (110) 110
rodents (110) 110
membrane attack complex (108) 108
pathogenesis (108) 108
receptor (108) 108
complement c5a - metabolism (106) 106
medicine (106) 106
neurosciences (103) 103
alternative pathway (102) 102
complement activation - immunology (102) 102
care and treatment (101) 101
disease (100) 100
pharmacology & pharmacy (100) 100
surgery (100) 100
c5a receptor (97) 97
hemolytic-uremic syndrome (94) 94
antibodies, monoclonal, humanized - therapeutic use (93) 93
cells (93) 93
complement c5a (93) 93
complement c5a - immunology (93) 93
in-vivo (92) 92
signal transduction (91) 91
complement c5 - immunology (90) 90
aged (89) 89
antibodies (89) 89
decay-accelerating factor (89) 89
cells, cultured (88) 88
ischemia-reperfusion injury (88) 88
multidisciplinary sciences (88) 88
pathology (87) 87
abridged index medicus (86) 86
eculizumab (86) 86
inhibition (86) 86
apoptosis (85) 85
complement c5 - metabolism (85) 85
complement component c5a (85) 85
urology & nephrology (84) 84
complement c3 - metabolism (83) 83
inflammation - immunology (83) 83
review (83) 83
immunity, innate (82) 82
neutrophils - immunology (82) 82
complement system proteins - physiology (81) 81
development and progression (81) 81
sepsis (79) 79
tumor-necrosis-factor (79) 79
genetic aspects (78) 78
macular degeneration (77) 77
enzyme-linked immunosorbent assay (76) 76
medicine & public health (76) 76
paroxysmal-nocturnal hemoglobinuria (76) 76
rheumatology (76) 76
complement component c3 (75) 75
immune response (74) 74
chemical and pharmacologic phenomena (73) 73
risk factors (73) 73
anaphylatoxin (72) 72
endothelial-cells (72) 72
receptor, anaphylatoxin c5a - metabolism (72) 72
gene expression (71) 71
antibodies, monoclonal - therapeutic use (70) 70
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2004) 2004
German (4) 4
Japanese (4) 4
Russian (4) 4
French (3) 3
Spanish (3) 3
Hebrew (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Leukocyte Biology, ISSN 0741-5400, 01/2017, Volume 101, Issue 1, pp. 193 - 204
The host is protected by pattern recognition systems, including complement and TLRs, which are closely cross‐talking. If improperly activated, these systems... 
innate immunity | inflammation | therapy | Therapy | Innate immunity | Inflammation | C1-ESTERASE INHIBITOR | HEMOLYTIC-UREMIC SYNDROME | HUMAN WHOLE-BLOOD | ESCHERICHIA-COLI SEPSIS | PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA | IMMUNOLOGY | CELL BIOLOGY | ISCHEMIA-REPERFUSION INJURY | SIGNAL-TRANSDUCTION | POLYMICROBIAL SEPSIS | NEUROMYELITIS-OPTICA | DOUBLE-BLIND | HEMATOLOGY | Inflammation - therapy | Complement C3 - antagonists & inhibitors | Animals | Complement C5 - metabolism | Complement C3 - metabolism | Humans | Inflammation - immunology | Toll-Like Receptors - metabolism | Molecular Targeted Therapy | Complement C5 - antagonists & inhibitors | Lipopolysaccharide Receptors - metabolism | Pathogenesis | Clinical trials | Activation | Complement | CD14 antigen | Immunity | Inflammatory diseases | Interleukin 6 | Proteins | Receptors | Toll-like receptors | Inhibition | Immune system | Pattern recognition systems | Immune response | Cytokines | Upstream | Pattern recognition | TLR4 protein | Diseases | Complement component C5 | Tumor necrosis factor | Complement component C3 | TLR2 protein | Sepsis | VDP | Medisinske Fag: 700 | Reviews | Basic Medicine | Immunologi | Immunology | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Immunologi inom det medicinska området | Immunology in the medical area
Journal Article
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2013, Volume 368, Issue 23, pp. 2169 - 2181
Journal Article